Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta.
about
Krüppel-like factor 4 interacts with p300 to activate mitofusin 2 gene expression induced by all-trans retinoic acid in VSMCsAdenosine A(2A) receptors promote collagen production by a Fli1- and CTGF-mediated mechanism.CCN2 is required for the TGF-β induced activation of Smad1-Erk1/2 signaling networkDecreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosisA possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosisItga2b regulation at the onset of definitive hematopoiesis and commitment to differentiation.Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.Fli1 represses transcription of the human α2(I) collagen gene by recruitment of the HDAC1/p300 complex.Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient miceAbnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemiaThe c-Abl tyrosine kinase controls protein kinase Cδ-induced Fli-1 phosphorylation in human dermal fibroblasts.Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFβ suppressionFli1 is a negative regulator of estrogen receptor α in dermal fibroblastsThe impact of Fli1 deficiency on the pathogenesis of systemic sclerosisNoncanonical transforming growth factor beta signaling in scleroderma fibrosisNovel electrostatic mechanism for mode of action by N-acetylated proteins: cell signaling and phosphorylation.Animal models of scleroderma: current state and recent development.The ets transcription factor Fli-1 in development, cancer and disease.Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features.Vasculopathy in scleroderma.Recent advances in animal models of systemic sclerosis.Instructive role of M-CSF on commitment of bipotent myeloid cells involves ERK-dependent positive and negative signaling.Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability.Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.Drug-mediated inhibition of Fli-1 for the treatment of leukemia.Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis: a preliminary report of three cases.Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.Constitutive activation of c-Abl/protein kinase C-δ/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma.The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway.Fli1 deficiency and beyond: a unique pathway linking peripheral vasculopathy and dermal fibrosis in systemic sclerosis.
P2860
Q28582872-9BCBD20A-A2EB-4EE7-9338-AF545458D85BQ33765783-7D20DB38-5200-4673-B2C4-B671E38149E5Q33961583-EF8359B7-A12E-43FF-ACEB-6AB0D1057493Q34010829-DFDAF56A-360D-4F00-9F57-1D2B825D9A36Q34182447-A10DAB32-EE89-488E-873A-1B389C11E246Q34405062-9DE2A414-CE5C-4780-B374-E45E75321C39Q34721223-39985534-5564-4EAA-BA6B-01E2B0366548Q34994922-EED66E11-B47B-4EAC-A919-E19D9F7C69D8Q35127552-3FFADC8A-8DDA-47C3-9BBC-12DEF99F361AQ35553360-72AE323A-8D28-4AD3-BA4F-B0FF0CB87898Q36054245-1DE1C16D-33B1-4D5B-A282-F90322BA33F6Q36426379-3B80C04C-A799-47C4-9914-B5B735B8C5ECQ37301981-6A8CB9D8-DAB1-4C6C-BE4C-D4EF3DC99FF1Q37305155-2BC89BE1-FCB2-4D19-90CA-AC718249C48EQ37588466-D6FFBA57-4187-4946-95A1-790608FFDEF9Q37880883-396E5ADF-82C6-40F0-90BC-5100DD9734E0Q38154834-C71B826B-4DB6-4ECE-8D76-500788959204Q38218534-A01C0E21-20A2-48AB-891E-9C949F6E7D48Q38489606-E6752BF5-5686-4159-8F7C-181E5E526093Q38543688-DADD1790-1BA5-417E-AD6D-4EBB5F00B4A1Q38701983-705E50F9-1E90-4D4E-B1E1-C03946D0943BQ38838269-6F018714-D56F-4416-9352-57BFB9B08BF0Q38868948-F05879D6-977D-4673-8808-BD30BFE5BBA4Q40785888-D37B3F42-B162-4734-9502-D909EBF3F416Q40787191-1018E97C-5D1B-48FF-9F72-5AB17EB7E4EEQ43498045-A262B1A4-6945-4076-8725-30B86616E28BQ44449871-A4DD02A4-7F61-4111-8BCC-2232DCDCD841Q44878948-CC59A02B-E750-4B68-815C-A2E79DD092B5Q47399059-E1A2A5D2-ED4A-40BD-9202-281E551B7622Q53662594-D39592E2-B49E-431E-8429-010180DF7E93
P2860
Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Phosphorylation of Fli1 at thr ...... ansforming growth factor beta.
@en
Phosphorylation of Fli1 at thr ...... ansforming growth factor beta.
@nl
type
label
Phosphorylation of Fli1 at thr ...... ansforming growth factor beta.
@en
Phosphorylation of Fli1 at thr ...... ansforming growth factor beta.
@nl
prefLabel
Phosphorylation of Fli1 at thr ...... ansforming growth factor beta.
@en
Phosphorylation of Fli1 at thr ...... ansforming growth factor beta.
@nl
P2860
P356
P1476
Phosphorylation of Fli1 at thr ...... ansforming growth factor beta.
@en
P2093
Yoshihide Asano
P2860
P304
P356
10.1128/MCB.01320-08
P407
P577
2009-01-21T00:00:00Z